Venture Capital Investors

DROIA

DROIA is a VC investing group that backs high-potential tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

DROIA is a venture investor, exclusively focused on the development of oncology therapies. We are dedicated to making a difference in the fight against cancer. We have adopted a unique investment model to accelerate development in our portfolio companies. We aim to bring promising therapies to patients faster, creating both patient benefit and shareholder value. Hence our name: Double Return On Investment, Accelerated: DROIA. The holding is funded by European private investors and operates from offices in Luxembourg and Brussels. We invest worldwide.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/20/2021

Transaction History

Our records indicate that DROIA invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Partner

Luc Dochez

        

Managing Partner

Janwillem Naesens

        

Principal

Sandra Schoors

        

Managing Partner

Bart Van Hooland

        

Principal

Matthias Van Woensel

        

Principal

Joke Vereecken

        

Founder

Luc Verelst

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

DROIA has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Driventure | Droia Ventures

Share this article

About Our VC Investors Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary